New Postdoc Funding Opportunities
Summer 2024 NCI Pathway to Independence Award for Outstanding Early-Stage Postdoctoral Researchers (K99/R00)
Internal Applications Due March 21 at 5 p.m.
VU and VUMC may each submit one application per scientific focus area to the NCI Pathway to Independence Award for Outstanding Early-Stage Postdoctoral Researchers (K99/R00) programs. The scientific focus areas are Cancer Data Science, Cancer Control Science, Molecular/Precision Cancer Prevention and Other Cancer Research. There are three separate RFAs, which allow different types of proposed research (e.g. basic, clinical): PAR-23-286, PAR-23-287, and PAR-23-288. Each of VU and VUMC's four selected applicants (1/focus area) may apply to whichever RFAs best suit their research proposals.
The objective of the NCI Pathway to Independence Award is to help outstanding postdoctoral researchers complete needed, mentored career training and transition in a timely manner to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. The K99/R00 award is intended to foster the development of a creative, independent research program that will be competitive for subsequent independent funding and that will help advance the mission of the NCI.
This program is designed for outstanding postdoctoral fellows with research and/or clinical doctoral degrees who do not require extended periods of mentored research training beyond their original doctoral degrees before transitioning to research independence. Researchers in the scientific areas of cancer control, cancer prevention and cancer data sciences are especially encouraged to apply.
Individuals must be in mentored, postdoctoral training positions to be eligible to apply to the K99/R00 program. The K99/R00 award will provide up to 5 years of support in two phases. The initial (K99) phase will provide support for up to 2 years of mentored postdoctoral research training and career development. The second (R00) phase will provide up to 3 years of independent research support, which is contingent on satisfactory progress during the K99 phase and obtaining an approved, independent tenure-track (or equivalent) faculty position.
The award covers up to $100,000 per year toward the salary of the career award recipient, and up to $30,000 per year toward the research development costs of the award recipient.
See solicitations for full program and eligibility details:
PAR-23-286 - Independent Clinical Trial Not Allowed
PAR-23-287 - Independent Clinical Trial Required
PAR-23-288 - Independent Basic Experimental Studies with Humans Required
| |
See solicitations for full program and eligibility details:
- PAR-23-286 - Independent Clinical Trial Not Allowed
- PAR-23-287 - Independent Clinical Trial Require
- PAR-23-288 - Independent Basic Experimental Studies with Humans Required
| |
Internal Application Process:
Anyone interested in being considered to submit a proposal must submit the following materials by 5 p.m. on March 21, 2024.
Note the different submission instructions for VU and VUMC postdocs, below.
- Brief (2-page maximum) research plan including summary budget;
- Statement of support from department chair/center director;
- NIH Biosketch
For VU-employed Postdocs:
- Submit all application materials via InfoReady by March 21, 2024.
- In your application, indicate to which RFA and which scientific focus area (cancer data science, cancer control science, molecular/precision cancer prevention, or other cancer research) you would apply.
- Any questions about this opportunity, eligibility, or the LSO process may be directed to
VU-LSO@vanderbilt.edu.
For VUMC-employed Postdocs:
- Submit all application materials in a single PDF to lso@vanderbilt.edu by March 21, 2024.
- Visit the OOR site for more detail.
- In your email, indicate to which RFA and which scientific focus area (cancer data science, cancer control science, molecular/precision cancer prevention, or other cancer research ) you would apply.
- Any questions about this opportunity, eligibility, or the LSO process may be directed to LSO@vanderbilt.edu.
| |
Catalyst to Independence AwardLOI Due March 14
The third cycle of Additional Ventures Catalyst to Independence Award is now open and accepting LOIs until March 14. The award is intended to support investigators pursuing research with relevance to single ventricle congenital heart defects, including genetics, tissue engineering, computational modeling, pre- and neonatal health, and basic cardiovascular development as outlined in the Research Roadmap.
This $1M transition award offers up to five years of support (similar to a K99/R00, with 2 years in the Level I mentored/postdoc phase, 3 years in the Level II independent phase) and additionally provides professional development opportunities, including one-on-one professional coaching and group workshops to develop lab and people management skills. Stipend levels are determined using the US General Schedule and start at GS-11. Funding includes annual research funds of $30,000 in Level I and $100,000 in Level II, with $50,000 available annually to cover research support staff plus an additional supplement for health and family care.
| |
This award is open to any researchers who meet the following criteria:
- Earned a PhD, MD, DVM, DO or doctoral equivalent 1-year before the award start date
- Current postdoc (or equivalent) status in a non-independent, mentored position
- Must commit a minimum of 9 calendar months (75% effort) to the proposed work
- Affiliated with a domestic nonprofit academic or research institution
- Must be legally qualified to work in the US (including citizens, non-citizen permanent residents, or temporary residents of the US)
| |
LOIs will be accepted until March 14, and full proposals are due on April 18.
The full RFP for this call can be found on the Additional Ventures website and includes details on the program, including the application process.
| |
|
|
|
|
